The thrombogenic risk induced by intraportal infusion of adult derived human liver stem/mesenchymal cells in Wister rats can be controlled with a combination of anticoagulant drugs, heparin and bivalirduin.

作者
Louise Coppin,Milena Rozzi,Mina Komuta,Sandrine Horman,Etienne Marc Sokal,Xavier Stéphenne
出处
期刊:Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B) - Digital Access to Libraries
摘要

Introduction Mesenchymal Stem cell (MSC) transplantation is a fast emerging therapy for regenerative medicine. However MSCs express a procoagulant activity (PCA) inducing a thrombogenic risk in recipient patients. This thrombogenic risk is due to activation of the coagulation cascade, triggered by Tissue Factor (TF) on MSCs, resulting in fibrin production and platelet consumption. In vitro the PCA of Adult Derived Human Liver Stem/Mesenchymal Cells (ADHLSCs) can be controlled by an anticoagulant cocktail, combining an antithrombin activator (Heparin) and a thrombin inhibitor (Bivalirudin). Aim The aim was to study in vivo, the effect of an anticoagulant cocktail on thrombogenic risk induced by intraportal ADHLSCs. First we wanted to characterize the thrombogenic events induced by ADHLSCs infusion. Then we wanted to study the effect of the anticoagulant cocktail on these events. Finally the effect of cell dosage on the thrombogenic risk was studied. Methods Wistar rats (n=3 per group) were infused with ADHLSCs through an intraportal catheter. Rats were infused with 3 different cell dosages (50, 12.5 and 5 million ADHLSCs/kg), with or without administration of anticoagulant therapy (Heparin and Bivalirudin). Control group was infused with PBS. Blood samples were collected before and 1 hour after cell infusion. Hemoglobin and platelet levels were analysed with an automated hematology analyzer, Cell-Dynn Emerald (Abbott). Rats were sacrified and liver tissue was collected 1 hour after cell infusion. Serial slides were performed to analyse the localisation of AHDLSCs (human Beta 1 integrin staining) and fibrin (P.T.A.H. coloration). Cell quantification and localisation was analysed with digital imaging system, Visiopharm. Fibrin was analysed in Portal Veins (PV) containing ADHLSCs by digital imaging system, TissueIA. Results ADHLSCs intraportal infusion induced after 1 hour a significant decrease (p < 0.05) in platelet count with production of fibrin around the infused cells localized in PVs. No platelet consumption or fibrin production was observed in the control (PBS) group. In the anticoagulated group, platelets also decreased significantly (p < 0.05) but fibrin production was significantly (p < 0.001) reduced, from 86.6% ± 6.4 to 26.4% ± 13.8. When different cell dosages were infused, we observed a correlation between the number of infused cells and the number of cells in the liver. The number of cells in liver tissue (cells/mm2) and the number of PVs containing cells (PVs containing cells/total PV) were significantly (p < 0.01) lower when lower cell dosages were used, compared to the higher cell dosage group. Consumption of platelets was also correlated to cell dosage. No decrease in platelets was observed when 5x106cells/kg were infused without anticoagulation, and when 12.5x106cells/kg were infused with anticoagulation. Platelets tended to decrease less in the high cell dose group, 50x106cells/kg when anticoagulant therapy was administered. No significant difference has been observed in the production of fibrin in PVs between the different cell dosages. In all conditions, hemoglobin did not decrease significantly, meaning that blood sampling did not interfere with our results. Conclusions Intraportal infusion of ADHLSCs activated the coagulation cascade resulting in fibrin formation and platelet consumption 1hour after cell infusion. The use of a combination of anticoagulant drugs, heparin and bivalirudin, could prevent the formation of fibrin, but a significant decrease in platelets was still observed. However this decrease tends to be less and can even be controlled when lower cell dosages are used. The production of fibrin and thus the activation of the coagulation cascade was not dependent of cell dosage.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
一心怡意发布了新的文献求助30
2秒前
Clover完成签到,获得积分10
2秒前
六道发布了新的文献求助10
2秒前
苏以禾完成签到 ,获得积分10
2秒前
小陈完成签到,获得积分10
2秒前
Owen的应助被向着阳光奔跑采纳,获得10
3秒前
4秒前
老迟到的羊完成签到 ,获得积分10
4秒前
eating完成签到,获得积分10
5秒前
乐乐的应助被小马同学采纳,获得10
5秒前
5秒前
5秒前
5秒前
单薄开山发布了新的文献求助10
6秒前
丁真人发布了新的文献求助10
6秒前
Passskd完成签到,获得积分10
6秒前
7秒前
wxg完成签到,获得积分10
7秒前
zhaoben发布了新的文献求助10
8秒前
科研通AI6.3的应助被TSW采纳,获得10
8秒前
9秒前
wst1988完成签到,获得积分0
9秒前
Tsuns完成签到,获得积分10
9秒前
郭娅楠发布了新的文献求助10
10秒前
133完成签到 ,获得积分10
10秒前
10秒前
10秒前
11秒前
syvshc的应助被calm采纳,获得10
12秒前
12秒前
小红发布了新的文献求助10
12秒前
12秒前
桃子汽水发布了新的文献求助10
13秒前
13秒前
黄智清完成签到,获得积分10
13秒前
笨笨山芙完成签到,获得积分0
14秒前
bkagyin的应助被波纹疾走打字机采纳,获得10
16秒前
思源的应助被李涵睿采纳,获得10
16秒前
郑睿涛发布了新的文献求助10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183792
求助须知:如何正确求助?哪些是违规求助? 9573020
关于积分的说明 21828776
捐赠科研通 7780959
什么是DOI,文献DOI怎么找? 3434116
关于科研通互助平台的介绍 2558301
邀请新用户注册赠送积分活动 2480611